SCHEMBL21760177

SCHEMBL21760177

Ic1ccc2c(c1)NCCC2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2A P08913 1/20 0.44
PNMT P11086 1/20 0.44
ADRA2B P18089 1/20 0.44
ADRA2C P18825 1/20 0.44
HRH3 Q9Y5N1 1/20 0.42
MAPT P10636 3/20 0.42
KDM4E B2RXH2 2/20 0.42
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA9 Q16790 1/20 0.41
ALDH1A1 P00352 1/20 0.39
LMNA P02545 1/20 0.39
TP53 P04637 1/20 0.39
GAA P10253 1/20 0.39
THRB P10828 1/20 0.39
ALOX15 P16050 1/20 0.39
CASP1 P29466 1/20 0.39
HTT P42858 1/20 0.39
CASP7 P55210 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30487745 1.00 ADRA2A (0.44) ADRA2APNMTADRA2BADRA2CHRH3
SCHEMBL981053 0.88 ADRA2A (0.52) ADRA2APNMTADRA2BADRA2CMAPT
SCHEMBL30584650 0.88 ADRA2A (0.52) ADRA2APNMTADRA2BADRA2CMAPT
SCHEMBL566283 0.84 MAPT (0.54) ADRA2APNMTADRA2BADRA2CHRH3
Acetaldehyde SCHEMBL27764807 0.78 ADRA2A (0.43) ADRA2APNMTADRA2BADRA2CMAPT
SCHEMBL596333 0.76 PNMT (0.48) ADRA2APNMTADRA2BADRA2CHRH3
SCHEMBL3873031 0.76 HTR2A (0.47) ADRA2APNMTADRA2BADRA2CHRH3
SCHEMBL15320816 0.76 MAPT (0.46) HRH3MAPTKDM4ECA12CA1
SCHEMBL3111834 0.76 MAPT (0.50) HRH3MAPTKDM4ECA12CA1
SCHEMBL12821127 0.76 HRH3 (0.42) HRH3MAPTKDM4ECA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240352035-A1 NEAR-INFRARED NERVE-SPARING BENZO[C]PHENOXAZINE FLUOROPHORES OREGON HEALTH & SCIENCE UNIVERSITY (US) 2024-10-24 US disclosed
US-12030893-B2 Near-infrared nerve-sparing benzo[c]phenoxazine fluorophores OREGON HEALTH & SCIENCE UNIVERSITY (US) 2024-07-09 US disclosed
US-12030893-B2 Near-infrared nerve-sparing benzo[c]phenoxazine fluorophores OREGON HEALTH & SCIENCE UNIVERSITY (US) 2024-07-09 US disclosed
US-12030893-B2 Near-infrared nerve-sparing benzo[c]phenoxazine fluorophores OREGON HEALTH & SCIENCE UNIVERSITY (US) 2024-07-09 US disclosed
EP-3849496-B1 NEAR-INFRARED NERVE-SPARING BENZO[C]PHENOXAZINE FLUOROPHORES UNIV OREGON HEALTH & SCIENCE (US) 2023-10-25 EP disclosed
EP-3849496-B1 NEAR-INFRARED NERVE-SPARING BENZO[C]PHENOXAZINE FLUOROPHORES UNIV OREGON HEALTH & SCIENCE (US) 2023-10-25 EP disclosed
CN-112804982-B Near infrared nerve-retaining benzo [ c ] phenoxazine fluorophores 俄勒冈健康与科学大学 2023-07-25 CN disclosed
US-20230210854-A1 MONO- AND COMBINATION THERAPIES RECURIUM IP HOLDINGS, LLC 2023-07-06 US disclosed
EP-3807274-B1 4-SUBSTITUTED PYRROLO[2,3-B]PYRIDINE AS ERBB MODULATORS USEFUL FOR TREATING CANCER LEAD DISCOVERY CENTER GMBH (DE) 2022-07-27 EP disclosed
US-20220041619-A1 NEAR-INFRARED NERVE-SPARING BENZO[C]PHENOXAZINE FLUOROPHORES OREGON HEALTH & SCIENCE UNIVERSITY (US) 2022-02-10 US disclosed
US-20220041619-A1 NEAR-INFRARED NERVE-SPARING BENZO[C]PHENOXAZINE FLUOROPHORES OREGON HEALTH & SCIENCE UNIVERSITY (US) 2022-02-10 US disclosed
CN-112804982-A Benzo [ c ] phenoxazine fluorophores for near-infrared nerve retention 俄勒冈健康与科学大学 2021-05-14 CN disclosed
WO-2020056046-A1 NEAR-INFRARED NERVE-SPARING BENZO[C]PHENOXAZINE FLUOROPHORES OREGON HEALTH & SCIENCE UNIVERSITY (US) 2020-03-19 WO disclosed
WO-2020039060-A1 4-SUBSTITUTED PYRROLO[2,3-B]PYRIDINE AS ERBB MODULATORS USEFUL FOR TREATING CANCER LEAD DISCOVERY CENTER GMBH (DE) 2020-02-27 WO disclosed
EP-3613738-A1 4-SUBSTITUTED PYRROLO[2,3-B]PYRIDINE AS ERBB MODULATORS USEFUL FOR TREATING CANCER Lead Discovery Center GmbH (DE) 2020-02-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240352035-A1 NEAR-INFRARED NERVE-SPARING BENZO[C]PHENOXAZINE FLUOROPHORES NTRK1, PMP22, PAX3 ADRA2A 668/4885PNMT 193/4885ADRA2B 461/4885
US-12030893-B2 Near-infrared nerve-sparing benzo[c]phenoxazine fluorophores NTRK1, PMP22, PAX3 ADRA2A 668/4885PNMT 193/4885ADRA2B 461/4885
US-20230210854-A1 MONO- AND COMBINATION THERAPIES TP53, BRCA1, MCL1 ADRA2A 2826/4885PNMT 1888/4885ADRA2B 2503/4885
US-20220041619-A1 NEAR-INFRARED NERVE-SPARING BENZO[C]PHENOXAZINE FLUOROPHORES NTRK1, PMP22, PAX3 ADRA2A 668/4885PNMT 193/4885ADRA2B 461/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.